SR biotek Inc. (XKON:270210)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,350
+1,650 (5.21%)
At close: Feb 27, 2026

SR biotek Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2016FY 2015
Period Ending
Feb '26 Dec '16 Dec '15
Debt / Equity Ratio
3.153.152.95
Debt / EBITDA Ratio
5.695.692.82
Debt / FCF Ratio
76.3876.38-
Net Debt / Equity Ratio
2.492.492.21
Net Debt / EBITDA Ratio
4.504.502.11
Net Debt / FCF Ratio
60.3660.36-0.89
Asset Turnover
0.610.61-
Inventory Turnover
2.982.98-
Quick Ratio
0.450.450.72
Current Ratio
0.780.781.26
Return on Equity (ROE)
-13.21%-13.21%-
Return on Assets (ROA)
1.20%1.20%-
Return on Invested Capital (ROIC)
2.65%2.65%22.68%
Return on Capital Employed (ROCE)
3.10%3.10%21.30%
Buyback Yield / Dilution
--0.02%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.